Advertisement

Search Results

Advertisement



Your search for GOVIND PERSAD, JD, PhD,GOVIND PERSAD, JD, PhD matches 16 pages

Showing 1 - 16


issues in oncology

Medical-Legal Partnerships: A Promising Innovation in Oncology

Beyond the physical toll of the disease and its treatments, cancer often presents a host of legal and social issues that can significantly worsen a patient’s well-being and treatment outcomes. This column explains how medical-legal partnerships can offer a powerful tool to address these challenges ...

issues in oncology

Failure to Diagnose and Statutes of Limitations: Lavern’s Law and Its Implications for Oncology

When health-care providers, including oncologists, fail to promptly diagnose a medical condition or communicate their diagnosis to their patients, it can have devastating consequences for those patients. In such cases, patients may seek legal recourse through medical malpractice lawsuits, creating...

issues in oncology

Understanding the Legal and Ethical Challenges AI Poses in Oncology

The field of oncology is experiencing a revolution driven by artificial intelligence (AI) technology. Artificial intelligence tools are already being used in medical imaging analysis, treatment planning, and even patient counseling. These advancements hold immense promise for earlier cancer...

issues in oncology

Reflections on Cancer’s Toll on My Family

Over the past 2 years, my family and I have experienced firsthand the challenges of cancer. In the spring of 2021, my mother was diagnosed with stage IIB pancreatic cancer. She died in mid-2023 after developing metastatic disease, including peritoneal carcinomatosis. The experience has caused me to ...

issues in oncology

Distributing Scarce Cancer Drugs Legally and Ethically

During the COVID-19 pandemic, many medical specialties became familiar with supply chain interruptions resulting in drug, equipment, and personnel scarcity. Intensive care unit beds, staff, and essential medicines were at times in short supply. The federal government, individual states, and...

issues in oncology

Addressing Health Disparities in Oncology Care—Legally and Ethically

A health disparity is typically defined as involving a differential in health outcomes between some groups of patients and other groups, for example, between White and Black patients, in which some groups fare better than others. Health inequities are commonly defined as health differences that...

cost of care

Understanding the Health Provisions in the Inflation Reduction Act and Their Implications for Oncology Care

The Inflation Reduction Act of 2022, signed into law on August 16, 2022, contains several important provisions regarding health care and drug pricing.1 In this article, I provide an overview of the legislation’s implications for oncology care, focusing on its provisions concerning drug price...

issues in oncology

Legal and Ethical Use of Complementary and Alternative Medicine Interventions in Oncology

In addition to, or instead of, receiving therapies that are the standard of care, patients with cancer sometimes request to receive complementary (therapies used in conjunction with standard cancer treatment) and alternative (nonstandard treatments used in place of standard cancer treatment)...

issues in oncology
integrative oncology

Legal and Ethical Use of Complementary and Alternative Medicine Interventions in Oncology

In addition to, or instead of, receiving therapies that are the standard of care, patients with cancer sometimes request to receive complementary (therapies used in conjunction with standard cancer treatment) and alternative (nonstandard treatments used in place of standard cancer treatment)...

issues in oncology

What the Supreme Court’s Abortion Decision Means for Patients With Cancer and Their Clinicians

On June 24, 2022, the Supreme Court ruled in Dobbs v Jackson Women’s Health Organization (Dobbs)1 and overturned Roe v Wade and Planned Parenthood v Casey, which recognized a federal constitutional right to end a pregnancy up to the point of viability. This decision opened the door for states to...

Oncology Care in the Ongoing COVID-19 Pandemic: Expert Commentary

Recently, Govind Persad, JD, PhD, of the University of Denver Sturm College of Law, wrote an op-ed for The ASCO Post entitled “Oncology Care Remains Under Strain in the Ongoing COVID-19 Pandemic.” On this episode of the podcast, Dr. Persad further discusses the challenges that patients with cancer...

covid-19

Oncology Care Remains Under Strain in the Ongoing COVID-19 Pandemic

The resurging COVID-19 pandemic has reawakened challenges for patients and physicians—ones we all hoped were over—and presented stressful situations for patients and providers. Hospitals in some states, particularly those with lower vaccination rates, have faced levels of urgent illness that have...

health-care policy

How the Biden Administration Is Changing Oncology Care

A change in presidential administrations has implications across the health sector, including for oncology. In this column, we review some recent actions by Congress and the Biden administration and their implications for the oncology community. We focus on three areas: funding for patients and...

issues in oncology

Challenges Related to Informed Consent and Information-Sharing for Minors With Cancer

Here we discuss a complex and often emotionally wrenching challenge related to informed consent in the provision of pediatric cancer care. For example, what legal and ethical claims do young patients have to information about their cancer diagnosis and treatment recommendations? What are the...

issues in oncology
covid-19

How Telemedicine Is Impacting Oncology Care During the COVID-19 Pandemic

The expansion of telemedicine has been one of the most important developments during the COVID-19 pandemic. Here, we discuss some of the legal and ethical dimensions of expanding telemedicine services in oncology practices. As Royce et al discussed in a recent JAMA Oncology article, Congress...

issues in oncology

Developing Policies to Address Patient Racial Bias and Race-Based Provider Requests

Public momentum for efforts to address structural and systemic racism has led many health-care institutions to consider how they can work to bring about positive change. In this column, drawing on important recent work by Kimani Paul-Emile, JD, PhD, Professor of Law at Fordham University School of ...

Advertisement

Advertisement




Advertisement